Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy — Stella

Recruiting

Back to Post Prostatectomy trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

Princess Margaret Cancer Centre, Toronto, Ontario

Key details

Sponsor

University Health Network, Toronto

Enrollment target

~100 participants

Started

May 2017

Primary completion

September 2027

Age range

18 Years and older

Sex

Male only

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov